<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160523028010N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-04</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of crystalloid infusion  containing 2% glucose on blood pressure and heart rate in cesarean section with spinal anesthesia</public_title>
      <acronym></acronym>
      <scientific_title>The effect of crystalloid infusion  containing 2% glucose on hemodynamic status in cesarean section with spinal anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64306</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: For this purpose, the envelope method will be used. For this purpose, four sheets of paper were prepared. The letter I will be written on two sheets and the letter C will be written on the other two sheets. The leaves are placed in the envelope and after mixing, we will put them in the table drawer. Upon referral to any of the eligible patients, one of the sheets will be randomly pulled out and based on this sheet, I or C will be assigned to one of the two intervention groups (I and control (C)). When all four sheets are accidentally pulled out, all the sheets will be returned to the drawer and the above operation will be continued for the next four patients until the desired sample size is reached, Blinding description: In both groups I and C, serums containing glucose and distilled water are prepared and injected by the nurse, so the anesthesiologist who will measure and record the study outcome, also the person undergoing cesarean section will not know the type of drug prescribed did not have.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hemodynamic change during cesarean.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: pregnant women receiving Ringer's serum containing 2% glucose20 grams of glucose are added per liter of Ringer's serum, after the pregnant woman is placed on the surgical bed, the infusion of Ringer's serum containing glucose starts and continues until the end of the surgery. The mother's blood sugar is measured before and after the surgery.The baby's blood sugar is checked immediately after birth and one hour after that.Systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate are measured before the start of spinal anesthesia, immediately after spinal anesthesia, every two minutes to ten minutes, and then every ten minutes until the end of the surgery. Shivering, nausea and vomiting, if any, are recorded until the end of the operation. If the systolic pressure is less than 90 mmHg, 20-5 mg of ephedrine and the heart rate is less than 50 per minute, 0.5 mg of atropine is injected. Intervention 2: Control group: pregnant women receiving Ringer's serum Normal saline is added per liter of Ringer's serum, equivalent to the volume of glucose added in the intervention group. After the pregnant woman is placed on the surgical bed, Ringer's serum infusion starts and continues until the end of the surgery. The mother's blood sugar is measured before and after the surgery. The baby's blood sugar is checked immediately after birth and one hour after that, systolic, diastolic and average blood pressure and heart rate are measured before starting spinal anesthesia, immediately after spinal anesthesia, every two minutes to ten minutes, and then every ten minutes until the end of surgery. Shivering, nausea, and vomiting, if any, are recorded until the end of the procedure. If the systolic pressure is less than 90 mmHg, 20-5 mg of ephedrine and the heart rate is less than 50 per minute, 0.5 mg of atropine is injected.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The possibility of adding a new participant</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Pouran Hajian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan university of medical sciences Faculty of medicine ,Shahid Fahmideh Blvd</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838695</zip>
        <telephone>+98 81 3838 0572</telephone>
        <email>hajian@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Pouran Hajian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Science,Faculty of medicine; Shahid Fahmideh Blvd</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838695</zip>
        <telephone>+98 81 3838 0572</telephone>
        <email>hajian@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18 -45 year
Gestational age (38-42 week)
Single tone pregnancy
Elective cesarean under spinal anesthesia
ASA I
Consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>psychotic disorders
BMI&gt;35kg/m2
Emergency cesarean
Systemic diseses(renal,cardiac,pulmonary,hepatic, musculoskeletal ,... disorders)
Intolerance to glucose
Taking drugs that affect glucose metabolism
Contraindications to spinal anesthesia
Allergy to bupivacaine</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: pregnant women receiving Ringer's serum containing 2% glucose20 grams of glucose are added per liter of Ringer's serum, after the pregnant woman is placed on the surgical bed, the infusion of Ringer's serum containing glucose starts and continues until the end of the surgery. The mother's blood sugar is measured before and after the surgery.The baby's blood sugar is checked immediately after birth and one hour after that.Systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate are measured before the start of spinal anesthesia, immediately after spinal anesthesia, every two minutes to ten minutes, and then every ten minutes until the end of the surgery. Shivering, nausea and vomiting, if any, are recorded until the end of the operation. If the systolic pressure is less than 90 mmHg, 20-5 mg of ephedrine and the heart rate is less than 50 per minute, 0.5 mg of atropine is injected.</i_keyword>
      <i_keyword>Control group: pregnant women receiving Ringer's serum Normal saline is added per liter of Ringer's serum, equivalent to the volume of glucose added in the intervention group. After the pregnant woman is placed on the surgical bed, Ringer's serum infusion starts and continues until the end of the surgery. The mother's blood sugar is measured before and after the surgery. The baby's blood sugar is checked immediately after birth and one hour after that, systolic, diastolic and average blood pressure and heart rate are measured before starting spinal anesthesia, immediately after spinal anesthesia, every two minutes to ten minutes, and then every ten minutes until the end of surgery. Shivering, nausea, and vomiting, if any, are recorded until the end of the procedure. If the systolic pressure is less than 90 mmHg, 20-5 mg of ephedrine and the heart rate is less than 50 per minute, 0.5 mg of atropine is injected.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in blood pressure. Timepoint: Upon arrival, before and immediately after the spinal and every 2 minutes to the first ten minutes and then every 10 minutes until the end of the operation was recorded. Method of measurement: Standard monitoring device.</prim_outcome>
      <prim_outcome>Changes of Heart rate. Timepoint: Upon arrival, before and immediately after the spinal and every 2 minutes to the first ten minutes and then every 10 minutes until the end of the operation was recorded. Method of measurement: Standard monitoring device.</prim_outcome>
      <prim_outcome>Percent of patient with blood pressure less than 90  mmHg. Timepoint: none. Method of measurement: Standard monitoring device.</prim_outcome>
      <prim_outcome>Percent of patient with heart rate less than 50 per minute. Timepoint: none. Method of measurement: Standard monitoring device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Nausea and  vomiting. Timepoint: Every two minutes for ten minute and then every ten minute until end of surgery. Method of measurement: through observation.</sec_outcome>
      <sec_outcome>Chills through observation. Timepoint: Every two minutes for ten minute and then every ten minute until end of surgery. Method of measurement: through observation.</sec_outcome>
      <sec_outcome>Hypoglycemia or hyperglycemia in mother. Timepoint: before surgery and at the end of surgery,. Method of measurement: based on Glucometery measurements.</sec_outcome>
      <sec_outcome>Hypoglycemia or hyperglycemia in infant. Timepoint: immediately after birth and one hour after birth. Method of measurement: based on Glucometery measurements.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-08</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Hamadan University of Medical Science, Shahid Fahmideh Blvd Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
